Part 1 of 3: S-ICD as a first-line therapy - PRAETORIAN & UNTOUCHED Trial Results

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Part 1 of 3: S-ICD as a first-line therapy - PRAETORIAN & UNTOUCHED Trial Results

By Boston Scientific FEATURING Ulrika Birgersdotter-Green, Michael Gold, Reinoud Knops

386 views

October 27, 2020

Join to hear Dr. Ulrika Birgersdotter-Green, Dr. Reinoud Knops, and Dr. Michael Gold discuss the ...
read more ↘ results from the PRAETORIAN & UNTOUCHED trials.
↖ read less

Comments 0

Product Workshop S-ICD as a first-line therapy: Results from the PRAETORIAN & UNTOUCHED Trials

02:53

Boston Scientific

Part 1 of 3: S-ICD as a first-line therapy - PRAETORIAN & UNTOUC…

Feat. U. Birgersdotter-Green, M. Gold, R. Knops

22:08

Boston Scientific

Part 2 of 3: PRAETORIAN Trial Results

Feat. R. Knops, U. Birgersdotter-Green

18:58

Boston Scientific

Part 3 of 3: UNTOUCHED Trial Results

Feat. M. Gold, U. Birgersdotter-Green

18:36

Boston Scientific

(REMOVED) Part 4 of 4: Q&A – PRAETORIAN & UNTOUCHED Trial Re…

Feat. U. Birgersdotter-Green, M. Gold, R. Knops

Thumbs Up

October 27, 2020

Atrioventricular Optimization Improves Cardiac Resynchronization Res…

Feat. M. Gold